Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study.
Authors: lionetti R
Date: May 2019
Scope of interest: infectious/hepatological
Authors: lionetti R
Date: May 2019
Scope of interest: infectious/hepatological
Authors:
Date: 2020
Scope of interest: Neurology/Emergency
Authors: Fanella M, Morano A, Fattouch J, Albini M, Casciato S, Manfredi M, Giallonardo AT, Di Bonaventura C.
Date: 2015
Scope of interest: Epilepsy
Authors: ilaria uccella
Date: 2018
Scope of interest: infectious disease training programs
Click on the icon of the service you are looking for and go to the dedicated section. If the service is not in the selection, go to Service Guide